Hugh J Willison Selected Research

Interferon Type I

1/2017

Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hugh J Willison Research Topics

Disease

43	Guillain-Barre Syndrome 01/2023 - 04/2002
20	Miller Fisher Syndrome (Fisher Syndrome) 12/2023 - 04/2002
12	Infections 12/2023 - 09/2002
10	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 12/2002
8	Paralysis (Palsy) 02/2012 - 09/2004
5	Zika Virus Infection 01/2023 - 04/2016
4	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 12/2023 - 11/2003
4	Enteritis 01/2018 - 07/2004
4	Ophthalmoplegia (External Ophthalmoplegia) 06/2005 - 04/2002
3	Demyelinating Diseases (Demyelinating Disease) 04/2017 - 01/2013
2	Pain (Aches) 12/2023 - 12/2023
2	Fatigue 12/2023 - 12/2023
2	Polyneuropathies (Polyneuropathy) 01/2023 - 10/2012
2	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2023 - 03/2013
2	Muscle Weakness 01/2023 - 06/2005
2	Central Nervous System Diseases (CNS Diseases) 01/2022 - 01/2021
2	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 10/2005
2	Gliosis 06/2019 - 01/2019
2	Ataxia (Dyssynergia) 06/2005 - 08/2002
1	Myasthenia Gravis 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2021
1	COVID-19 01/2021
1	Arbovirus Infections 01/2021
1	Dengue (Dengue Fever) 10/2020
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 04/2017
1	acute flaccid myelitis 12/2016
1	Necrosis 03/2012
1	Multiple Sclerosis 09/2011
1	Keratoconjunctivitis 01/2011
1	Gaucher Disease (Gaucher's Disease) 10/2008
1	Respiratory Paralysis 05/2008
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2008
1	Disease Progression 02/2008
1	Diarrhea 02/2008
1	Bacterial Infections (Bacterial Infection) 04/2004
1	Spider Bites (Spider Bite) 11/2003
1	Neuromuscular Diseases (Neuromuscular Disease) 10/2003

Drug/Important Bio-Agent (IBA)

42	AntibodiesIBA 12/2023 - 04/2002
41	GangliosidesIBA 12/2023 - 08/2002
16	AutoantibodiesIBA 01/2023 - 08/2002
12	Complement System Proteins (Complement)IBA 01/2022 - 11/2003
11	GlycolipidsIBA 01/2023 - 08/2002
8	Intravenous Immunoglobulins (IVIG)FDA Link 12/2023 - 10/2003
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2009
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2011
5	Immunoglobulin G (IgG)IBA 01/2023 - 02/2008
5	OligosaccharidesIBA 01/2018 - 08/2002
4	AntigensIBA 01/2023 - 10/2008
4	Immunoglobulin M (IgM)IBA 10/2020 - 12/2002
4	Polysaccharides (Glycans)IBA 01/2018 - 01/2011
4	alpha-latrotoxinIBA 11/2005 - 04/2002
3	Amantadine (Aman)FDA LinkGeneric 04/2016 - 02/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 12/2023
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 12/2023 - 12/2023
2	Carbamazepine (Tegretol)FDA LinkGeneric 12/2023 - 12/2023
2	IV(4)-galactosyl-N-acetylganglioside GD1aIBA 01/2023 - 01/2021
2	calpain inhibitorsIBA 01/2023 - 11/2003
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 07/2010
2	Heparin (Liquaemin)FDA LinkGeneric 06/2019 - 01/2019
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 03/2016 - 08/2005
2	Glycoproteins (Glycoprotein)IBA 01/2014 - 01/2011
2	EpitopesIBA 11/2005 - 04/2004
2	LipopolysaccharidesIBA 07/2004 - 09/2002
1	calpastatinIBA 01/2023
1	galactocerebrosideIBA 01/2023
1	sulfate-3-glucuronyl paraglobosideIBA 01/2023
1	NAD+ Nucleosidase (NAD(P) Nucleosidase)IBA 01/2022
1	CalciumIBA 01/2022
1	CalpainIBA 01/2022
1	N-Methylaspartate (NMDA)IBA 01/2022
1	TubulinIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 11/2021
1	COVID-19 VaccinesIBA 01/2021
1	Viral RNAIBA 10/2020
1	Cell Adhesion MoleculesIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 04/2017
1	Interferon Type IIBA 01/2017
1	Complement C5 (Complement 5)IBA 03/2016
1	GlycosphingolipidsIBA 02/2014
1	Oligoclonal BandsIBA 09/2011
1	LipidsIBA 09/2011
1	Botulinum Toxins (Botulinum Toxin)IBA 12/2008
1	eculizumab FDA Link 05/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2005
1	Prednisolone (Predate)FDA LinkGeneric 11/2003
1	Therapeutic UsesIBA 10/2003
1	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2002

Therapy/Procedure

3	Plasma Exchange 01/2019 - 12/2016
2	Critical Care (Surgical Intensive Care) 10/2020 - 04/2016
2	Therapeutics 01/2018 - 10/2005
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Length of Stay 10/2020
1	Immunotherapy 01/2019
1	Intraperitoneal Injections 05/2008
1	Intravenous Injections 05/2008
1	Plasmapheresis 10/2005